MediFind found 467 doctor with experience in Marginal Zone Lymphoma (MZL) near Pennsylvania, US. Of these, 426 are Experienced, 36 are Advanced, 4 are Distinguished and 1 are Elite.
Abramson Cancer Center Perelman 4th Floor West
Stefan Barta is a Hematologist in Philadelphia, Pennsylvania. Dr. Barta is rated as an Elite provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Non-Hodgkin Lymphoma, T-Cell Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Barta is currently accepting new patients.
Temple Faculty Practice Plan Inc
Henry Fung is a Hematologist Oncology specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Fung is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Lehigh Valley Physician Group
Mariette Austin is an Oncologist and a Hematologist in Allentown, Pennsylvania. Dr. Austin is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Follicular Lymphoma, Breast Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma.
UPMC Altoona Radiology
A leading specialist in endovascular medicine with experience in vascular and interventional radiology, Dr. Sergei Sobolevsky has decades of experience in the field. Using real-time imaging technology for precise navigation during minimally invasive interventions, he’s adept at diagnosing and treating a range of conditions. From his modern facility at the Downtown Vein & Vascular Center in Brooklyn, Dr. Sobolevsky offer discrete but complete services. Call today for a consultation.Sergei Sobolevsky, MD is an endovascular specialist with extensive experience in image-guided minimally invasive medicine and vascular and interventional radiology. To provide the best possible care, he provides targeted, proven procedures with your safety and goals in mind. At his practice, the Downtown Vein & Vascular Center, he and his dedicated team focus primarily on vein and artery conditions, including peripheral artery disease, as well as uterine fibroids conditions.Dr. Sobolevsky has performed over 25,000 procedures. From his office in Downtown Brooklyn, he serves all of Brooklyn, including Brooklyn Heights, Boerum Hill, Clinton Hill, Cobble Hill, DUMBO, Fort Greene and the Navy Yard, as well as greater New York City. For the best vein and artery treatments or fibroids treatments, visit Dr. Sobolevsky at his state-of-the-art facility.Dr. Sobolevsky’s educational background is as impressive as his professional career. He graduated in 1997 from the University of Colorado School of Medicine with his Doctor of Medicine (MD) degree. He received his specialty clinical training in vascular and interventional radiology at Harvard University. Later, he completed his MBA at the MIT Sloan School of Management to help him manage his practice better. In between, he filled the years with hard work and dedication not only to his theoretical knowledge, but also to his practical skills. He received surgical training at the Robert Wood Johnson University Hospital-New Brunswick. He then spent three additional years studying diagnostic radiology at the SUNY Downstate Medical Center. He completed his specialty training in Cardiovascular Interventional Radiology at the Beth Israel Deaconess Medical Center of Harvard University in Boston.He’s been recognized as a Castle Connolly Top Doctor and named to the Top Doctors New York Metro Area in 2020, 2021 and 2022. While attending medical school, he received a prestigious award for the Best Western Medical Student Research.He has published extensively from his research, his expertise and his collaborations in many peer-reviewed journals.He has a license to practice in the State of New York, as well as in other states, including AL, AZ, CO, CT, IL, LA, MA, MI, KY, ND, NJ, PA, and TX.He served on the Board of Directors at the New York Roentgen Ray Society in 2017, 2018 and 2019. Dr. Sobolevsky is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Ascites, Colorectal Cancer, Familial Colorectal Cancer, Prostatic Artery Embolization, and Gastrostomy.
Temple Faculty Practice Plan Inc
Mark Hallman is a Radiation Oncologist and a General Surgeon in Philadelphia, Pennsylvania. Dr. Hallman has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Prostate Cancer, Familial Prostate Cancer, and Cystectomy.
Jefferson University Physicians
Pierluigi Porcu is an Oncologist and a Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Porcu is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Bone Marrow Transplant, and Bone Marrow Aspiration.
Temple Faculty Practice Plan Inc
Jason Incorvati is a Hematologist Oncology specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Incorvati has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Chronic Myelogenous Leukemia (CML).
Main Line Healthcare
Jonathan Gefen is a General Surgeon in Wynewood, Pennsylvania. Dr. Gefen is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Hernia, Cholecystitis, Gallbladder Disease, Hernia Surgery, and Gallbladder Removal.
Temple Faculty Practice Plan Inc
Alan Haber is a Pulmonary Medicine provider in Philadelphia, Pennsylvania. Dr. Haber is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Lung Metastases, Lung Cancer, Chronic Obstructive Pulmonary Disease (COPD), and Muscle Invasive Bladder Cancer.
Temple Faculty Practice Plan Inc
Rohit Kumar is a Pulmonary Medicine provider in Philadelphia, Pennsylvania. Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Lung Nodules, Lung Cancer, Lung Metastases, Endoscopy, and Advanced Bronchoscopy.
Temple Faculty Practice Plan Inc
Thomas Galloway is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Galloway is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Laryngeal Cancer, Throat Cancer, Adenoid Cystic Carcinoma, Tongue Cancer, and Glossectomy.
Temple Faculty Practice Plan Inc
Michael Hall is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Hall is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Familial Colorectal Cancer, and Gastroesophageal Junction Cancer.
Einstein Practice Plan Inc
John Leighton is a Hematologist Oncology specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Leighton is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Familial Colorectal Cancer, Paget Disease of the Breast, Breast Cancer, and End-Stage Renal Disease (ESRD).
Wellspan Medical Group
Lesley Hughes is a Radiation Oncologist in Ephrata, Pennsylvania. Dr. Hughes is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Anal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).
Temple Faculty Practice Plan Inc
Joshua Meyer is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Meyer is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Anal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Lung Cancer.
Main Line Healthcare
Michael Walker is a Thoracic Surgeon and a General Surgeon in Paoli, Pennsylvania. Dr. Walker is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Lung Nodules, Thymectomy, and Advanced Bronchoscopy.
Temple Faculty Practice Plan Inc
Stacey Su is a Thoracic Surgeon and a General Surgeon in Philadelphia, Pennsylvania. Dr. Su is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Nodules, Thymectomy, and Endoscopy.
Temple Faculty Practice Plan Inc
Michael Styler is a Hematologist Oncology specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Styler is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Multiple Myeloma, Colorectal Cancer, Bone Marrow Transplant, and Bone Marrow Aspiration.
Temple Faculty Practice Plan Inc
Rashmi Khanal is a Hematologist Oncology specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Khanal is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Temple Faculty Practice Plan Inc
Marcin Chwistek is an Oncologist and a Palliative Medicine provider in Philadelphia, Pennsylvania. Dr. Chwistek is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma.
Last Updated: 10/30/2025
